Posts - CLL Support | HealthUnlocked
Treatments & trials posts
Sort posts by:
Ibrutinib-Venetoclax is the recommended first-line therapy for fit Arab patients with CLL in the Gulf region
A group of CLL experts from across the Gulf region and an international expert f...
Chemo-free treatment with acalabrutinib can benefit CLL/SLL patients never treated before: a plain language summary of the ELEVATE-TN study
The ELEVATE-TN international study commenced in September 2015. The plain langu...
Want to take advantage of all our features? Just log in!
or
Improving Treatment Options for Patients with Double Refractory CLL - patients who progressed after treatment with both cBTKis and BCL2i
Abstract
The proliferation and survival of chronic lymphocytic leukemia (CLL...
BTK Is the Target That Keeps on Giving: A Review of BTK-Degrader Drug Development, Clinical Data, and Future Directions in CLL
Here's a welcome article that explains all about BTK degraders; the next class o...
Why does ibrutinib cause nail brittleness (onychorrhexis and onychoschizia) or curly hair in some CLL patients? What can you do about it?
A fairly common observation of those taking the BTK inhibitor ibrutinib is that ...
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor. (BRUIN CLL-321 Phase III trial results reported at ASH2024)
Pirtobrutinib is the first FDA approved non-covalent BTK inhibitor (BTKi) for th...
Real-world incidence and prevention of tumor lysis syndrome (TLS) in chronic lymphocytic leukemia (CLL) treated with venetoclax. From MSK
A few members who have been recommended ventoclax/Venclexta treatment, have post...
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Phase 2 CLL2-BAAG trial results from the German CLL Study Group
Some very encouraging news for those with unmutated IGHV and/or TP53 aberrations...
Write a post or ask a question